Samir Jabbour

Dr. Jabbour est un ophtalmologiste clinicien-chercheur spécialisé dans le traitement des maladies complexes du segment antérieur de l'œil, notamment les greffes de cornée et la reconstruction de la surface oculaire, y compris les greffes de cellules souches limbiques. Ses domaines de recherche englobent les affections de la surface oculaire, ainsi que les techniques avancées en kératoplastie, chirurgie de la cataracte et chirurgie réfractive. Par ailleurs, Dr. Jabbour possède une expertise en santé publique et poursuit actuellement une maîtrise avec une concentration en épidémiologie et biostatistique.

• 2023-présent        Professeur adjoint de clinique - Université McGill, Montréal, QC
• 2022-présent        Master in Public Health (MPH) - Harvard University, Boston, MA
• 2021-présent        Professeur adjoint de clinique - Université de Montréal, Montréal, QC
• 2020-2021            Fellowship clinique en cornée, segment antérieur et chirurgie réfractive / Moorfields Eye Hospital NHS Foundation Trust, Londres, GB
• 2020                     American Board of Ophthalmology (ABO), U.S.A.
• 2019-2020            Fellowship clinique en cornée, segment antérieur et chirurgie réfractive / Wilmer Eye Institute, Johns Hopkins School of Medicine, Baltimore, MD
• 2019                     Collège Royal des Médecins et Chirurgiens du Canada (FRCSC) en Ophtalmologie
• 2016                     Licence en Médecine du Collège Canadien (LMCC)
• 2016                     National Board of Medical Examination U.S.A. (NBME)
• 2014-2019            Diplôme d’études spécialisées, Résidence en ophtalmologie / Université de Montréal, Montréal, QC
• 2010-2014            M.D.C.M. / Université McGill, Montréal, QC
• 2007-2010            B.Sc. (Physiologie) / Université McGill, Montréal, QC
• 2007                     Baccalauréat Français Scientifique, Normandie, France

Cho K, Ali M, Heckenlaible NJ, Jabbour S, Jun AS, Srikumaran D. Outcomes and Early Complications Using an Endothelium-in Pull-Through Descemet Membrane Endothelial Keratoplasty Technique With Preloaded Versus Surgeon-Loaded Donor Tissue in Fuchs Patients [published online ahead of print, 2023 Aug 22]. Cornea.

Moussa S, Tong M, Robert MC, Harissi-Dagher M, Ahmad S, Jabbour S. Survey: Preferred practice patterns in the diagnosis of mucous membrane pemphigoid amongst cornea specialists [published online ahead of print, 2023 May 24]. Eur J Ophthalmol.

Karam M, Alkhowaiter N, Alkhabbaz A, Jabbour S (et al.) Extended Depth of Focus Versus Trifocal for Intraocular Lens Implantation: An Updated Systematic Review and Meta-Analysis. Am J Ophthalmol. 2023;251:52-70.

Sun KJ, Jun AS, Bohm K, Daroszewski D, Jabbour S. Corneal thinning following bevacizumab intrastromal injection for the treatment of idiopathic lipid keratopathy. Am J Ophthalmol Case Rep. 2022;27:101618.

Szigiato AA, Touma S, Jabbour S, Lord F, Agoumi Y, Singh H. Efficacy of ab-interno gelatin microstent implantation in primary and refractory glaucoma. Can J Ophthalmol. 2023;58(4):328-337.
Phylactou M, Jabbour S, Ahmad S, Vasquez-Perez A. Corneal Perforation in Patients Under Treatment With Dupilumab for Atopic Dermatitis. Cornea. 2022;41(8):981-985.

Jabbour S, Phylactou M, Ahmad S. Ocular mucous membrane pemphigoid: novel treatment strategies. Curr Opin Allergy Clin Immunol.

Jabbour S, Bower KS* (2021). Refractive Surgery in the US in 2021. JAMA 2021; 326:77-78

Akpek EK, Karakus S, Yohannan J, Jabbour S et al. Reliability of Several Glaucoma Tests in Patients With Boston Type 1 Keratoprosthesis. Cornea. 2022;41(3):310-316.

Jabbour S, Din N, Logeswaran A, Sanchez ST, Ahmad S* (2021). Clinical Characteristics of Patients with Chronic Stevens-Johnson Syndrome Treated at a Major Tertiary Eye Hospital Within the United Kingdom. Front Med (Lausanne) 2021; 8:644795

Jabbour S*, Bower KS (2021). Three-year Outcomes of Implantable Collamer Lens Followed by Excimer Laser Enhancement (“Bioptics”) in the Treatment of High Myopic Astigmatism. Clin Ophthalmol 2021; 15:635-643

Ansah D, Wang J, Lu K, Jabbour S, Bower KS, Soiberman U* (2020). Post-FDA approval results of epithelium-off, full-fluence, Dresden protocol corneal collagen cross-linking in the USA. Ophthalmol Ther 2020; 9:1023-1040

Jabbour S, Jun AS, Shekhawat NS, Woreta FA, Krick T, Srikumaran D* (2020). Descemet Membrane Endothelial Keratoplasty (DMEK) Using a Pull-Through Technique with Novel Infusion Forceps. Cornea 2020; 40:387-292.

Jabbour S*, Shekhawat NS, Chen A, Akpek EK, Woreta FA (2020). Herpes zoster ophthalmicus reactivation following Shingrix vaccination. Cornea 2020; 40:248-250

Jabbour S*, Hamel P, Soucy JP, Ospina LH (2020). Allgrove syndrome: a report of new pathological mutations in the AAAS gene. Cornea 2020; 39:782-783

Jabbour S*, Choremis J, Boutin T, Brunette I, Mabon M, Talajic J (2019). Poor long-term outcomes of keratopigmentation with black ink for the treatment of dysphotopsia secondary to laser peripheral iridotomies. Cornea 2019; 38:1400–1405

Jabbour S*, Harissi-Dagher M, Agoumi Y, Singh H, Robert MC (2019) Outcomes of cyclophotocoagulation in the control of glaucoma in patients with the Boston Keratoprosthesis type 1. Cornea 2019;  39:181–185.

Jabbour S*, Talajic J, Mabon M, Modabber M, Choremis J (2019) Descemet membrane endothelial keratoplasty for epithelial downgrowth after cataract surgery. Can J Ophthalmol 2019;  54:e151-e153

Modabber M, Talajic J, Mabon M, Mercier M, Jabbour S, Choremis J* (2018). The role of novel DMEK graft shapes in facilitating intraoperative unscrolling. Graedes Arch Clin Exp Ophthalmol 2018; 256:2385-2390

Jabbour S*, Lesk M, Harissi-Dagher M (2018). Patch graft using collagen matrix (Ologen) for glaucoma drainage device exposure in a patient with the Boston Keratoprosthesis type 1. Am J Ophthalmol Case Rep 2018; 12:32-35

Fung SS*, Jabbour S, Harissi-Dagher M, Tan RR, Hamel P, Baig K, Ali A (2017). Visual outcomes and complications of type I Boston keratoprosthesis in children: a retrospective multicenter study and literature review. Ophthalmology 2017; 125:153-160

Jabbour S*, Muzychuk A, Agoumi, Harissi-Dagher M (2017). An unusual case of acute angle-closure glaucoma following deep anterior lamellar keratoplasty using the “big bubble” technique. Am J Ophthalmol Case Rep 2017; 7:126-128

Jabbour S*, Harissi-Dagher M (2017). Plugging the gap: Could frozen Boston Keratoprosthesis grafts end the cornea donor shortage? Expert Review of Ophthalmology 2017; 12:421-427

Jabbour S, Harissi-Dagher M. (2016). Recessive mutation in a nuclear-encoded mitochondrial tRNA synthetase associated with infantile cataract, congenital neurotrophic keratitis, and orbital myopathy. Cornea, 35(6), 894-896.

Haque M, Jabbour S, Fadlallah A, Harissi-Dagher M, Chelala E, Melki S* (2016). Integrity of intrastromal arcuate keratotomies performed by femtosecond laser. J Refract Surg 2016; 32:67-68

Zoroquiain P*, Jabbour S, Aldrees S, Villa N, Bravo-Filho V, Dietrich H., Burnier MN (2016). High frequency of squamous intraepithelial neoplasia in pterygium related to low ultraviolet light exposure. Saudi J Ophthalmol 2016; 30;113-116

Boutin T*, Jabbour S, Harissi-Dagher M (2015). Improving management and outcomes of the Boston type 1 keratoprosthesis: lessons learned from available evidence. Expert Review of Ophthalmology 2015; 10:229-239

Zoroquiain P*, Logan P, Bravo-Filho V, Vila N, Jabbour S, Orellana ME, Burnier MN (2015). Diagnosing Pathological Prognostic Factors in Retinoblastoma: Correlation between Traditional Microscopy and Digital Slides. Ocul Oncol Pathol 2015; 1:259-265

Jamal MH*, Hassanain M, Chaudhury P, Tran TT, Wong S, Yousef Y, Jozaghi Y, Salman A, Jabbour S, Simoneau E, Al‐Abbad S (2012). Staged hepatectomy for bilobar colorectal hepatic metastases. HPB 2012; 14:782-789.